TipRanks
Go Ultimate55% OFF

Compare MannKind (MNKD) vs. Competitors

Comparison Results

Comparison results
NamePriceMarket CapP/E RatioYearly GainAnalyst ConsensusAnalyst Price TargetCompareTop Analysts' Price TargetSmart ScoreFollow
MNKDMannKind$3.50$1.13B-25.09-36.94%Strong BuyUnlock the MNKD analyst price target with TipRanks PremiumMNKDUnlock the MNKD top-analyst price target with TipRanks Premium
LXRXLexicon Pharmaceuticals$1.42$631.84M-9.445.97%Strong BuyUnlock the LXRX analyst price target with TipRanks PremiumMNKD vs LXRXUnlock the LXRX top-analyst price target with TipRanks Premium
INVAInnoviva$21.22$1.53B4.3618.22%Strong BuyUnlock the INVA analyst price target with TipRanks PremiumMNKD vs INVAUnlock the INVA top-analyst price target with TipRanks Premium
SVRASavara$4.82$990.32M-8.3112.09%Strong BuyUnlock the SVRA analyst price target with TipRanks PremiumMNKD vs SVRAUnlock the SVRA top-analyst price target with TipRanks Premium
XERSXeris Pharmaceuticals$10.71$1.95B-110.3010.30%Strong BuyUnlock the XERS analyst price target with TipRanks PremiumMNKD vs XERSUnlock the XERS top-analyst price target with TipRanks Premium

Performance Comparison

-100%-50%0%50%100%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Performance comparison by fund
TickerCompany NamePriceChange% Change
MNKDMannKind3.50-1.98-36.13%
LXRXLexicon Pharmaceuticals1.420.064.41%
INVAInnoviva21.223.1117.17%
SVRASavara4.820.5512.88%
XERSXeris Pharmaceuticals10.710.818.18%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts